Litcius/Paper detail

TMEM16A (ANO1) as a therapeutic target in cystic fibrosis

Luis J. V. Galietta

2022Current Opinion in Pharmacology32 citationsDOI

Topics & Concepts

PotentiatorCystic fibrosisChloride channelMucusMucociliary clearanceSecretionCystic fibrosis transmembrane conductance regulatorAirwayStimulationMedicineChemistryPharmacologyCell biologyBiologyInternal medicineLungAnesthesiaEcologyCystic Fibrosis Research AdvancesAsthma and respiratory diseasesNeonatal Respiratory Health Research
TMEM16A (ANO1) as a therapeutic target in cystic fibrosis | Litcius